Starpharma Holdings Ltd has released a press release.
SPL7013 in VIRALEZE virucidal against Omicron
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Story so far
Earlier from Starpharma
- Interim Report and Half-Year Financial Results
- VIRALEZE sales and distribution in Saudi Arabia and GCC
- Starpharma - Quarterly Cashflow and Activities Report
- Starpharma receives $7.7M R&D tax incentive refund
- VIRALEZE successfully launched in Vietnam
Later from Starpharma
- Application for quotation of securities - SPL
- VIRALEZE to relaunch in the UK
- SPL7013 in VIRALEZE virucidal against influenza A and B
- SPL signs expanded DEP research agreement with US Biopharma
- VIRALEZE relaunched by LloydsPharmacy in the UK
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma